Rhumbline Advisers »

Allogene Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $469k 146k 3.21
2023-09-30 $441k 139k 3.17
2023-06-30 $717k 144k 4.97
2023-03-31 $638k 129k 4.94
2022-12-31 $789k 126k 6.29
2022-09-30 $1.4M 129k 10.80
2022-06-30 $1.4M 119k 11.40
2022-03-31 $769k 84k 9.11
2021-12-31 $1.3M 90k 14.92
2021-09-30 $2.3M 91k 25.70
2021-06-30 $2.3M 88k 26.08
2021-03-31 $2.2M 61k 35.30
2020-12-31 $1.7M 67k 25.24
2020-09-30 $2.4M 64k 37.72
2020-06-30 $3.3M 76k 42.82
2020-03-31 $1.1M 55k 19.44
2019-12-31 $1.4M 53k 25.98
2019-09-30 $1.4M 51k 27.25
2019-06-30 $1.4M 51k 26.85
2019-03-31 $906k 31k 28.90
2018-12-31 $829k 31k 26.93